1
Views
1
CrossRef citations to date
0
Altmetric
SYMPOSIUM: MANAGING DIABETES Core Curriculum Series #1 (Endocrinology and Metabolism)

Use of oral agents in treating diabetes mellitus a perspective

, MD, PhD
Pages 139-144 | Published online: 07 Jul 2016

References

  • The University Group Diabetes Program: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. I. Design, methods and baseline results. II. Mortality results. Diabetes 19(Suppl 2):747, 1970
  • Colwell AR, Colwell JA: Clinical use of oral sulfonylurea compounds in diabetes mellitus. Q Bull Northwestern Univ Med Sch 31:1, 1957
  • Colwell JA: Therapy with oral hypoglycemic agents. In Fajans SS, Sussman KE (Editors): Diabetes Mellitus: Diagnosis and Treatment. New York, American Diabetes Association, 1971, chap 26
  • Janbon M, Chaptol J, Vedel A, et al: Accidents hypoglycemiques graves par sulfamide thiadiazol. Montpell Med 21:441, 1942
  • Loubatières A: Physiologie et pharmacodynamie de certains dérives sulfamides hypoglycemiants. Contribution à l'étude des substances sythetiques à tropisme endocrinien. These Doct Sci Naturelles, Montpellier, No. 86. Montpellier, Causse, Graille et Castelnau, Ed, 1946
  • Knatterud GL, Meinert CL, Klimt CR, et al: Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenformin results. JAMA 217:777, 1971
  • Chalmers TC: The impact of controlled trials on the practice of medicine. Mt Sinai J Med NY 41:753, 1974
  • Oral Hypoglycemic Drugs. Proposed Labeling Requirements and Public Hearing. Fed Register 40:28587–28595, 1975
  • Colwell AR, Colwell JA: Pancreatic action of the sulfonylureas. J Lab Clin Med 53:376, 1959
  • Roth J, Prout TE, Goldfine ID, et al: Sulfonylureas: Effects in vivo and in vitro. Ann Intern Med 75:607, 1971
  • Kruger FA, Altschuld RA, Hollobaugh SL, et al: Studies on the site and mechanism of action of phenformin. II. Phenformin inhibition of glucose transport by rat intestine. Diabetes 19:50–52, 1970
  • Page OC, Hare RL, Stephens JW, et al: Toxicity of carbutamide: Report of a fatal bone marrow depression and anuria. N Engl J Med 256:74, 1957
  • Clarke BF, Campbell IW, Ewing DJ, et al: Generalized hypersensitivity reaction and visceral arteritis with fatal outcome during glibenclamide therapy. Diabetes 23:739, 1974
  • Van Thiel DH, De Bell R, Mellow M, et al: Tolazamide hepatotoxicity. Gastroenterology 67:506–510, 1974
  • Seltzer HS: Drug-induced hypoglycemia. A review based on 473 cases. Diabetes 21:955, 1972
  • Oliva PB: Lactic acidosis. Am J Med 48:209,1970
  • Schor SS: Statistical problems in clinical trials. Am J Med 55:727, 1973
  • Hales CN, Randle PJ: Effects of low-carbohydrate diet and diabetes mellitus on plasma concentrations of glucose, non-esterified fatty acids, and insulin during oral glucose-tolerance tests. Lancet 1:790, 1963
  • Seltzer HS, Allen EW, Herron AL Jr, et al: Insulin secretion in response to glycemic stimulus: Relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323, 1967
  • Colwell JA, Lein A: Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes 16:560, 1967
  • Kosaka K, Hagura R, Kuzuya T, et al: Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range. Diabetologia 10:775–782, 1974

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.